Abstract
Human pancreatic trypsin (hPT) is an established target for acute pancreatitis (AP) therapeutics. Here, a bioinformatics protocol of protein docking, peptide refinement, dynamics simulation and affinity analysis was described to perform rational design and molecular engineering of hPT peptide aptamers. Protein docking was employed to model the intermolecular interactions between hPT and its cognate inhibitory protein, the human pancreatic trypsin inhibitor (hTI). A number of peptide fragments were cut out from the interaction sites of docked hPT–hTI complexes, from which a decapeptide fragment 13LNGCTLEYRP22 was found to exhibit potent inhibition against hPT (K i = 5.3 ± 0.8 μM). We also carried out alanine scanning and virtual mutagenesis to systematically examine the independent contribution of peptide residues to binding affinity, and the harvested knowledge were then used to guide modification and optimization of the decapeptide fragment. Subsequently, inhibition studies of nine promising candidates against recombinant hPT were conducted, from which four samples were successfully identified to have high or moderate potency (K i < 10 μM). In particular, the peptides LQVCTLEYCN and LQICTLEYCT were found to inhibit hPT activity significantly (K i = 0.23 ± 0.04 and 0.85 ± 0.18 μM, respectively). Structural analysis of hPT–peptide complex systems unraveled diverse chemical interactions such as hydrogen bonds, salt bridges and hydrophobic forces across the complex interfaces.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
Steinberg, W. and S. Tenner (1994) Acute pancreatitis. New Engl. J. Med. 330: 1198–1210.
Fagenholz, P. J., C. Fernández-del Castillo, N. S. Harris, A. J. Pelletier, and C. A. Camargo (2007) Direct medical costs of acute pancreatitis hospitalizations in the United States. Pancreas 35: 302–307.
Yadav, D. and A. B. Lowenfels (2006) Trends in the epidemiology of the first attack of acute pancreatitis: A systematic review. Pancreas 33: 323–330.
Tenner, S., J. Baillie, J. DeWitt, and S. S. Vege (2013) American College of Gastroenterology guideline: Management of acute pancreatitis. Am. J. Gastroenterol. 108: 1400–1415.
Tenner, S. and P. A. Banks (1997) Acute pancreatitis: Nonsurgical management. World J. Surg. 21: 143–148.
Bassi, C., M. Falconi, E. Caldiron, R. Salvia, N. Sartori, G. Butturini, C. Contro, S. Marcucci, L. Casetti, and P. Pederzoli (1999) Assessment and treatment of severe pancreatitis protease inhibitor. Digestion 60: 5–8.
Li, Y., Q. Huang, S. Zhang, S. Liu, C. Chi, and Y. Tang (1994) Studies on an artificial trypsin inhibitor peptide derived from the mung bean trypsin inhibitor: chemical synthesis, refolding, and crystallographic analysis of its complex with trypsin. J. Biochem. 116: 18–25.
Guo, C. T., S. McClean, C. Shaw, P. F. Rao, M. Y. Ye, and A. J. Bjourson (2013) Trypsin and chymotrypsin inhibitor peptides from the venom of Chinese Daboia russellii siamensis. Toxicon 63: 154–164.
Smith, G. P. and V. A. Petrenko (1997) Phage display. Chem. Rev. 97: 391–410.
Szardenings, M. (2003) Phage display of random peptide libraries: Applications, limits, and potential. J. Recept. Signal. Transduct. Res. 23: 307–349.
Zhou, P., C. Wang, Y. Ren, C. Yang, and F. Tian (2013) Computational peptidology: A new and promising approach to therapeutic peptide design. Curr. Med. Chem. 20: 1985–1996.
Gaboriaud, C., L. Serre, O. Guy-Crotte, E. Forest, and J. C. Fontecilla-Camps (1996) Crystal structure of human trypsin 1: Unexpected phosphorylation of Tyr151. J. Mol. Biol. 259: 995–1010.
Salameh, M. A., A. S. Soares, A. Hockla, and E. S. Radisky (2008) Structural basis for accelerated cleavage of bovine pancreatic trypsin inhibitor (BPTI) by human mesotrypsin. J. Biol. Chem. 283: 4115–4123.
Polgár, L. (2005) The catalytic triad of serine peptidases. Cell Mol. Life Sci. 62: 2161–2172.
Colwell, L. J., B. P. Brenner, and A. W. Murray (2014) Conservation weighting functions enable covariance analyses to detect functionally important amino acids. PLoS ONE 9: e107723.
Wang, P., Y. Li, Q. Shao, W. Zhou, and K. Wang (2015) Targeting human secretory phospholipase A2 with designed peptide inhibitors for inflammatory therapy. J. Drug Target. 2: 140–146.
Berman, H. M., J. Westbrook, Z. Feng, G. Gilliland, T. N. Bhat, H. Weissig, I. N. Shindyalov, and P. E. Bourne (2000) The protein data bank. Nucleic Acids Res. 28: 235–242.
Ibrahim, S. B. and V. Pattabhi (2005) Trypsin inhibition by a peptide hormone: Crystal structure of trypsin-vasopressin complex. J. Mol. Biol. 348: 1191–1198.
Li, J., C. Zhang, X. Xu, J. Wang, H. Yu, R. Lai, and W. Gong (2007) Trypsin inhibitory loop is an excellent lead structure to design serine protease inhibitors and antimicrobial peptides. FASEB J. 21: 2466–2473.
Word, J. M., S. C. Lovell, J. S. Richardson, and D. C. Richardson (1999) Asparagine and glutamine: Using hydrogen atom contacts in the choice of side-chain amide orientation. J. Mol. Biol. 285: 1735–1747.
Rostkowski, M., M. H. Olsson, C. R. Søndergaard, and J. H. Jensen (2011) Graphical analysis of pH-dependent properties of proteins predicted using PROPKA. BMC Struct. Biol. 11: 6.
Chen, R., L. Li, and Z. Weng (2003) ZDOCK: An initial-stage protein-docking algorithm. Proteins 52: 80–87.
London, N., B. Raveh, E. Cohen, G. Fathi, and O. Schueler-Furman (2011) Rosetta FlexPepDock web server––high resolution modeling of peptide–protein interactions. Nucleic Acids Res. 39: W249–W253.
Raveh, B., N. London, and O. Schueler-Furman (2010) Sub-angstrom modeling of complexes between flexible peptides and globular proteins. Proteins 78: 2029–2040.
Duan, Y., C. Wu, S. Chowdhury, M. C. Lee, G. M. Xiong, and W. Zhang (2003) A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J. Comput. Chem. 24: 1999–2012.
Zhou, P., S. Zhang, Y. Wang, C. Yang, and J. Huang (2015) Structural modeling of HLA-B*1502/peptide/carbamazepine/Tcell receptor complex architecture: implication for the molecular mechanism of carbamazepine-induced Stevens-Johnson syndrome/ toxic epidermal necrolysis. J. Biomol. Struct. Dyn. (In press, doi: 10.1080/07391102.2015.1092476).
Darden, T., D. York, and L. Pedersen (1993) Particale mesh Ewald and N.log(N) method for Ewald sums in large systems. J. Chem. Phys. 98: 10089–10092.
Ryckaert, J., G. Ciccotti, and H. J. C. Berendsen (1997) Numerical-integration of cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 23: 327–341.
Kollman, P. A., I. Massova, C. Reyes, B. Kuhn, S. H. Huo, and L. Chong (2000) Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models. Acc. Chem. Res. 33: 889–897.
Case, D. (1994) Normal mode analysis of protein dynamics. Curr. Opin. Struct. Biol. 4: 285–290.
Hou, T., K. Chen, W. A. McLaughlin, B. Lu, and W. Wang (2006) Computational analysis and prediction of the binding motif and protein interacting partners of the Abl SH3 domain. PLoS Comput. Biol. 2: e1.
Song, G., M. Zhou, W. Chen, T. Chen, B. Walker, and C. Shaw (2008) HV-BBI––a novel amphibian skin Bowman-Birk-like trypsin inhibitor. Biochem. Biophys. Res. Commun. 372: 191–196.
Wang, M., L. Wang, T. Chen, B. Walker, M. Zhou, D. Sui, J. M. Conlon, and C. Shaw (2012) Identification and molecular cloning of a novel amphibian Bowman Birk-type trypsin inhibitor from the skin of the Hejiang Odorous Frog; Odorrana hejiangensis. Peptides 33: 245–250.
Morris, S. R. and J. A. Sakanari (1994) Characterization of the serine protease and serine protease inhibitor from the tissue-penetrating nematode Anisakis simplex. J. Biol. Chem. 269: 27650–27656.
Pierce, B. G., K. Wiehe, H. Hwang, B. H. Kim, T. Vreven, and Z. Weng (2014) ZDOCK server: interactive docking prediction of protein-protein complexes and symmetric multimers. Bioinformatics 30: 1771–1773.
Word, J. M., S. C. Lovell, T. H. LaBean, H. C. Taylor, M. E. Zalis, B. K. Presley, J. S. Richardson, and D. C. Richardson (1999) Visualizing and quantifying molecular goodness-of-fit: Small-probe contact dots with explicit hydrogen atoms. J. Mol. Biol. 285: 1711–1733.
Stein, A. and P. Aloy (2008) Contextual specificity in peptidemediated protein interactions. PLoS ONE 3: e2524.
Wallace, A. C., P. A. Laskowski, and J. M. Thornton (1995) LIGPLOT: A program to generate schematic diagrams of proteinligand interactions. Protein Eng. 8: 127–134.
Moreira, I. S., P. A. Fernandes, and M. J. Ramos (2007) Computational alanine scanning mutagenesis––an improved methodological approach. J. Comput. Chem. 28: 644–654.
Bi, J., H. Yang, H. Yan, R. Song, and J. Fan (2011) Knowledgebased virtual screening of HLA-A*0201-restricted CD8+ T-cell epitope peptides from herpes simplex virus genome. J. Theor. Biol. 281: 133–139.
Xiang, Z. and B. Honig (2001) Extending the accuracy limits of prediction of side-chain conformations. J. Mol. Biol. 311: 421–430.
Zhou, P., J. Huang, and F. Tian (2012) Specific noncovalent interactions at protein-ligand interface: Implications for rational drug design. Curr. Med. Chem. 19: 226–238.
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this work.
Rights and permissions
About this article
Cite this article
Shao, W., Zhu, W., Wang, Y. et al. Rational design and molecular engineering of peptide aptamers to target human pancreatic trypsin in acute pancreatitis. Biotechnol Bioproc E 21, 144–152 (2016). https://doi.org/10.1007/s12257-015-0638-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12257-015-0638-3